Analyst Research

Report Title Price
Provider: GlobalData
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd announces the Launch of Divalproex Sodium Extended - Release Tablets, USP

Thursday, 22 Aug 2013 08:30am EDT 

Dr.Reddy's Laboratories Ltd announced that it has launched Divalproex Sodium Extended - Release Tablets, USP (250 mg - 500mg), a therapeutic equivalent generic version of Depakote ER Tablet, Extended Release Tablets, USP was approved by the United Stated Food & Drug Administration (USFDA). 

Company Quote

-0.09 -0.18%
19 Dec 2014